Clinical Trials for NeOnc Technologies

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: NeOnc Technologies

Clinical Trials (4)

NCT06357377
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients with Pediatric Brain Tumors
PHASE1Not yet recruiting
15 participants
Started: Dec 31, 2024 · Completed: Oct 31, 2025
8 conditions1 sponsor0 locations
NCT06047379
Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
PHASE1/PHASE2Recruiting
134 participants
Started: Nov 1, 2023 · Completed: Aug 31, 2026
21 conditions1 sponsor2 locations
NCT05023018
NEO100 and High-Grade Meningioma
PHASE2Recruiting
30 participants
Started: Jul 1, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT02704858
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
PHASE1/PHASE2Recruiting
49 participants
Started: Aug 1, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor9 locations